Skip to main content
Fig. 4 | Orphanet Journal of Rare Diseases

Fig. 4

From: Evaluation of disease burden and response to treatment in adults with type 1 gaucher disease using a validated disease severity scoring system (DS3)

Fig. 4

Probabilities, based on baseline DS3 severity status (marked, moderate or mild), of living free of a a new episode of avascular necrosis, fracture or lytic bone lesion once GD1 treatment is begun [log-rank test for the difference among groups: P = 0.0007], b living free of a new episode of avascular necrosis or lytic bone lesion once GD1 treatment is begun (fracture events excluded [log-rank test for the difference among groups: P < 0.0001])

Back to article page

Orphanet Journal of Rare Diseases

ISSN: 1750-1172